Mutya Harsch, CLO and General Counsel at Foamix Pharmaceuticals Ltd. (FOMX), sold 639 shares at $2.35 ($2K) on 2019-07-01, disclosed to the SEC on 2019-07-03.
Open-market sale of $2k FOMX by CLO and General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |